| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/10/2008 | CN101262890A Use of aprotinin polypeptides as carriers in pharmaceutical conjugates |
| 09/10/2008 | CN101262883A Compositions and methods for eliciting an immune response to escape mutants of targeted therapies |
| 09/10/2008 | CN101262878A Therapeutic combination of HAMLET and a HDAC inhibitor to treat cancer |
| 09/10/2008 | CN101262876A Methods for treating B-cell malignancies using a TACI-IG fusion molecule |
| 09/10/2008 | CN101262872A Novel inhibitor of vascular endothelial growth factor expression |
| 09/10/2008 | CN101262861A Pharmaceutical for use in prevention and/or treatment of bowel disease |
| 09/10/2008 | CN101260157A Fusion polypeptide and application thereof in preparing antineoplastic, antiviral and intracellular bacterial parasite infection curing medicament |
| 09/10/2008 | CN101260156A Immunoglobulin single variant antigen binding domain and specific construct thereof |
| 09/10/2008 | CN101260154A Novel mhc II associated peptides |
| 09/10/2008 | CN101260153A Human breast carcinoma tissue antigen, and coding gene, preparation method and application thereof |
| 09/10/2008 | CN101260151A Separation and primary structure of sea purse blood vessel generation inhibitive factor 1, and application thereof in preparing blood vessel generation inhibiting medicament and antineoplastic medicam |
| 09/10/2008 | CN101260147A Modified blood vessel endothelium growth factor polypeptide segment and application thereof |
| 09/10/2008 | CN101260136A Oestrogen derivatives as inhibitors of steroid sulphatase |
| 09/10/2008 | CN101260135A Method for synthesizing higher fatty acid zidovudine ester |
| 09/10/2008 | CN101260121A Complex compound of heteroaromatic thiosemicarbazone and transition metal, and application thereof in preparing antineoplastic medicine |
| 09/10/2008 | CN101260106A Raf kinase inhibitor, preparing method and use thereof |
| 09/10/2008 | CN101260102A Antineoplastic activity marine indole alkaloids substances, and preparation method and application thereof |
| 09/10/2008 | CN101260099A Method for preparing antineoplastic effective composition bullatacin |
| 09/10/2008 | CN101260095A 13-halo-3,15-dioxygibberellic acid ester and preparation method thereof |
| 09/10/2008 | CN101260040A 5/7/6 type taxane diterpenoid, and medicament composition, synthesizing method and use thereof |
| 09/10/2008 | CN101259290A Preparation and application of target tumor intervention therapeutic agent |
| 09/10/2008 | CN101259287A Application of LDP protein as tumor target medicine guiding carrier |
| 09/10/2008 | CN101259284A Liver target anticancer nano prodrug system based on tree shaped polymer, preparation and use |
| 09/10/2008 | CN101259282A Tumor targeting macromolecule controlled-release anti-cancer medicine and synthesizing method and use |
| 09/10/2008 | CN101259279A Biocompatibile monodisperse nano polymer carrier and its preparation and medicine-carrying method |
| 09/10/2008 | CN101259270A Treatment of patients having non-hodgkins lymphoma with bone marrow involvement with anti-CD20 antibodies |
| 09/10/2008 | CN101259267A Compound type dual duplex locating type intracellular vaccine |
| 09/10/2008 | CN101259250A Medicaments assembly for activating blood circulation and removing stasis, softening dry feces and dissipating mass and preparation thereof |
| 09/10/2008 | CN101259238A Medicaments assembly for recuperating and nourishing liver and kidney, promoting qi and dispersing mass and preparation thereof |
| 09/10/2008 | CN101259235A Compound traditional Chinese medicine preparation for treating acute myeloblastic leukemia and producing method thereof |
| 09/10/2008 | CN101259223A Chinese herbal medicinal composition for treating leukemic |
| 09/10/2008 | CN101259192A Method for processing camellia chrysantha pollen |
| 09/10/2008 | CN101259180A Shenshe composition and preparation thereof |
| 09/10/2008 | CN101259166A Application of stephania tetrandra extract in preparing anti-tumor medicaments |
| 09/10/2008 | CN101259159A Preparation of alhagi sparsifolia total flavones and uses thereof |
| 09/10/2008 | CN101259131A Combination administration of an indolinone with a chemotherapeutic agent for cell proliferation disorders |
| 09/10/2008 | CN101259129A Combined treatment for acute leukemia and myelodysplastisches syndrom |
| 09/10/2008 | CN101259122A Use of hydroxyoleic acid and similar compounds in the production of medicaments |
| 09/10/2008 | CN101259121A Use of hydroxyoleic acid and similar compounds in the production of medicaments |
| 09/10/2008 | CN101259120A Methods of inducing terminal differentiation |
| 09/10/2008 | CN101259116A Externally-applied drug delivery preparations containing bullatacin part medicine exquisite articles |
| 09/10/2008 | CN101259103A Camptothecinum derivative emulsion agent and preparation thereof |
| 09/10/2008 | CN101259100A Etoposide preparations and preparation thereof |
| 09/10/2008 | CN101259099A Nano granule preparations of catharanthus roseus alkaloids anti-tumor medicaments and preparation thereof |
| 09/10/2008 | CN101259097A Magnetic tumor double-target polymer nano micelle and preparation thereof |
| 09/10/2008 | CN101258895A Negative ion-releasing selenium-rich odor-free multifunctional feed additive |
| 09/10/2008 | CN100417660C Ramification of pentacycle triterpene, preparation method and application |
| 09/10/2008 | CN100417648C 2-thioxothiazole derivative, method for preparing the same, and pharmaceutical composition containing the same |
| 09/10/2008 | CN100417421C Organic metal carborane target formulation and its preparation method |
| 09/10/2008 | CN100417418C Nucleic acid-containing complex |
| 09/10/2008 | CN100417397C Respiratory medicine for treating cancer, production method there for and specific application tool |
| 09/10/2008 | CN100417391C Composition comprising soluble glucan oligomer from saccharomyces cerevisiae is2 for immune activation or prevention and treatment of cancer and the preparation method thereof |
| 09/10/2008 | CN100417390C Effective part of sweet wormwood, its preparation method and application thereof in pharmacy |
| 09/10/2008 | CN100417378C Oridonin clathrate compound, and medicinal prepn. thereof |
| 09/10/2008 | CN100417377C Application of garcinolic acid in preparing medicine for treating tumor metastasis |
| 09/09/2008 | US7424529 System using host bus adapter connection tables and server tables to generate connection topology of servers and controllers |
| 09/09/2008 | US7423177 Carboxamide derivatives as therapeutic agents |
| 09/09/2008 | US7423170 Anticancer agents based on regulation of protein prenylation |
| 09/09/2008 | US7423148 Small molecule PI 3-kinase inhibitors and methods of their use |
| 09/09/2008 | US7423142 double-stranded ribonucleic acid (dsRNA); degradation of the mRNA transcript of the bcl-2 gene, thereby inhibiting expression of the target gene in the cell; anticarcinogenic agent |
| 09/09/2008 | US7423118 IAPS associated cell cycle proteins, compositions and methods of use |
| 09/09/2008 | US7423063 calcium salt is calcium trifluoroacetate; to prepare medicaments with cytotoxic and antitumoral activity |
| 09/09/2008 | US7423061 Anticarcinogenic agents; tert-butyl 3-{[(2-[(aminocarbonyl)amino]-5-{4-[2-(diethylamino)ethoxy]phenyl}-3-thienyl)carbonyl]amino}piperidine-1-carboxylate |
| 09/09/2008 | US7423060 Thiophene hydroxamic acid derivatives and their use as HDAC inhibitors |
| 09/09/2008 | US7423057 Dihydroorotate dehydrogenase (DHODH) inhibitors; Rheumatoid arthritis, Pneumocystis carinii, fibrosis, uveitis, rhinitis, asthma, and athropathy; 2-(Biphenyl-4-ylcarbamoyl)-cyclopent-1-enecarboxylic acid |
| 09/09/2008 | US7423055 e.g., 2-(2-methyl-5-amino)phenyl-4-(3-pyridyl)-thiazole; c-kit inhibitors; treating cell proliferative, metabolic, allergic, and degenerative disorders. |
| 09/09/2008 | US7423049 e.g., 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine; mitogen-activated protein kinase inhibitor; antiinflammatory agent, autoimmune diseases |
| 09/09/2008 | US7423047 Arylamine substituted bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 09/09/2008 | US7423043 4-Piperidin-1-yl-7H-pyrrolo[2,3-d]pyrimidine compounds |
| 09/09/2008 | US7423038 Compounds and compositions as protein kinase inhibitors |
| 09/09/2008 | US7423020 Therapy for behavior disorders; quantitative analysis; measuring binding |
| 09/09/2008 | US7423015 Treatment of p53-positive tumors with benzimidazole derivatives such as fenbendazole or mebendazole |
| 09/09/2008 | US7423011 Treating autoimmune diseases such as multiple sclerosis with CXCR4 antagonist such as peptides having of stromal cell derived factor one (SDF-1) sequences |
| 09/09/2008 | US7423007 Cxcr4 antagonist and use thereof |
| 09/09/2008 | US7422906 Apoptosis-inducing gene and utilization of the same |
| 09/09/2008 | US7422886 Human Phosphoinositide I3 Kinase p110 Delta which interacts with p85, has a broad phosphinositide specificity and is sensitive to the same kinase inhibitors as PI3 Kinase p110A; selectively expressed in leucocytes; enhanced expression in most melanomas |
| 09/09/2008 | US7422846 Detecting the activity of orphan G Protein Receptor 86 by incubating a sample comprising GPR86 and adenosine diphosphate (ADP) under binding conditions for both and detecting a second messanger; screening for a modulator |
| 09/09/2008 | US7422752 Mutant forms of EtxB and CtxB and their use as carriers |
| 09/09/2008 | US7422748 Combining antigen or in vivo generator with a surfactant or with a mixture of surfactants having an overall HLB number of between 5 and 15 and comprising: ethoxylated derivatives of ester of fatty acids and ethoxylated derivatives of oils |
| 09/09/2008 | US7422744 Integrin mediated diseases like angiogenesis or restenosis; Vitaxin (a humanized monoclonal) antibody and a LM609 grafted antibody exhibiting selective binding affinity to alpha v beta 3 |
| 09/09/2008 | US7422740 Capable of inhibiting the cell division cycle in a target cell; for therapy of proliferative cell disorders and intracellular pathogens |
| 09/09/2008 | US7422739 Anti-CD20 antibodies |
| 09/09/2008 | US7422733 Antiinflammatory agents; anticancer agents; antidiabetic agents |
| 09/09/2008 | CA2359357C Use of 5-ht5-ligands in the treatment of neurodegenerative and neuropsychiatric disturbances |
| 09/09/2008 | CA2323086C Regulation of endogenous gene expression in cells using zinc finger proteins |
| 09/09/2008 | CA2287881C Vitamin d3 analogs with bis c-20 side chains |
| 09/09/2008 | CA2260971C New bis-platinum complexes with polyamine ligands as antitumor agents |
| 09/09/2008 | CA2181689C Guanylhydrazones for treating inflammatory conditions |
| 09/09/2008 | CA2135833C Antigen carbohydrate compounds and their use in immunotherapy |
| 09/09/2008 | CA2124677C Immunopotentiatory agents and physiologically acceptable salts thereof |
| 09/04/2008 | WO2008106692A1 Pim kinase inhibitors and methods of their use |
| 09/04/2008 | WO2008106658A2 TRIGGERED RNAi |
| 09/04/2008 | WO2008106635A1 Pyrimidine-2,4-diamine derivatives and their use as jak2 kinase inhibitors |
| 09/04/2008 | WO2008106633A1 Methods of using benzodioxine compounds in treating sodium channel-mediated diseases or conditions |
| 09/04/2008 | WO2008106621A1 Taxane analogs for the treatment of brain cancer |
| 09/04/2008 | WO2008106600A1 Bazedoxifene bis-phosphorates |
| 09/04/2008 | WO2008106594A2 Inhibitors of nucleophosmin (npm) and methods for inducing apoptosis |
| 09/04/2008 | WO2008106524A1 Use of histone deacetylase inhibitors for the treatment of central nervous system metastases |
| 09/04/2008 | WO2008106479A2 Poly(1,4-piperazin-2-ones) as rod-like protein- protein interaction inhibitors and their production |
| 09/04/2008 | WO2008106248A1 Method of cancer treatment with naphthol analogs |